BioNexus Gene Lab Corp. Files 8-K on Shareholder Vote Matters
Ticker: BGLC · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1737523
| Field | Detail |
|---|---|
| Company | Bionexus Gene Lab CORP (BGLC) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
TL;DR
BioNexus Gene Lab Corp. is holding a shareholder vote on March 19th.
AI Summary
BioNexus Gene Lab Corp. filed an 8-K on March 25, 2025, reporting a submission of matters to a vote of security holders on March 19, 2025. The company, incorporated in Wyoming, is based in Kuala Lumpur and operates in the medical laboratories sector.
Why It Matters
This filing indicates that BioNexus Gene Lab Corp. is engaging in corporate actions requiring shareholder approval, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- BioNexus Gene Lab Corp. (company) — Filer of the 8-K report
- March 19, 2025 (date) — Date of the earliest event reported (submission of matters to a vote)
- March 25, 2025 (date) — Date the 8-K report was filed
- Wyoming (jurisdiction) — State of incorporation
- Kuala Lumpur (location) — Company's principal executive offices
FAQ
What specific matters were submitted for a vote of security holders?
The filing does not specify the exact matters submitted for a vote, only that such a submission occurred on March 19, 2025.
When was the 8-K filing submitted?
The 8-K filing was submitted as of March 25, 2025.
Where are BioNexus Gene Lab Corp.'s principal executive offices located?
The company's principal executive offices are located in Kuala Lumpur.
In which U.S. state is BioNexus Gene Lab Corp. incorporated?
BioNexus Gene Lab Corp. is incorporated in Wyoming.
What is the SIC code for BioNexus Gene Lab Corp.?
The Standard Industrial Classification (SIC) code for BioNexus Gene Lab Corp. is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding BioNexus Gene Lab Corp (BGLC).